GlassScriptPhysician profile
Ishani Patel
NPI 1356070254
$2,830.97
in general payments reported to CMS, 2019-2025
12 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $738 · 2023: $694 · 2024: $1,282 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,349 · Travel and Lodging: $646 · Education: $97.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,348.58 |
| Travel and Lodging | $646.48 |
| Education | $97.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,272.06 | 2022-2024 | Precision 7, Rocklatan |
| Mallinckrodt Hospital Products INC. | $525.83 | 2022-2023 | Acthar |
| Sun Pharmaceutical Industries INC. | $294.00 | 2022-2023 | Cequa |
| Oyster Point Pharma, INC. | $168.26 | 2022-2023 | Tyrvaya |
| Horizon Therapeutics Plc | $152.95 | 2022-2023 | Tepezza |
| Johnson & Johnson Vision Care, INC. | $144.50 | 2024-2025 | Acuvue |
| Abbvie INC. | $114.21 | 2022-2024 | |
| Apellis Pharmaceuticals, INC. | $42.61 | 2023 | Syfovre |
| Bausch & Lomb Americas INC. | $42.60 | 2024 | Infuse |
| Novartis Pharmaceuticals Corporation | $33.13 | 2022-2023 | |
| Coherus Oncology, INC. | $21.28 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.54 | 2023 | Eylea |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ishani Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.